Profile image
Story Views

Last Hour:
Last 24 Hours:

BRIC Blood Glucose Devices Market

Friday, November 18, 2016 3:00
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Diabetes population in the BRIC region is growing continuously. All four BRIC countries diabetes population is growing year on year due to their growing population and double digit diabetes prevalence. Diabetes prevalence rate in Russia was 11.1 percent in 2015, highest among the all BRIC countries.  At present, more than 12 Million Russian population is suffering from diabetes. China is having a diabetes prevalence of 10.6 percent followed by Brazil with 10.2 percent. India has the lowest diabetes prevalence among all with 8.7 percent.   

From 2006 the number of diabetic patients in Russia has grown by 60% percent. The Russian government is taking several initiatives to control diabetes. From 1996 to 2002 a total of USD 198 Million have been spent on Federal Targeted Programme on Diabetes. From 2002 till 2012 a sub-programme on diabetes is being introduced into Federal Targeted Programme on Diabetes.

Russia direct annual cost of diabetes is USD 12.5 Billion. Out of this 9 percent of direct cost is associated with diabetes drugs market, Blood Glucose Device Market. 42 percent of the cost is associated with diabetes related complications and rest 49 percent is associated with hospitalisation, outpatient services and other care.     

Contact Us

Renub Research

USA: +1-678-302-0700

India: +91-120-421-9822




Follow us:



Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.